PRZOOM - /newswire/ -
Palo Alto, CA, United States, 2008/05/13 - CoenzymeQ10 is a potent antioxidant well-recognized for its proven heart health benefits, including its ability to aid in the production of cellular energy, support healthy vision, alleviate migraines and reduce infertility.
These benefits, along with a rise in preventive healthcare, drive the U.S. supplements market for CoQ10.
New analysis from Frost & Sullivan (food.frost.com), U.S. CoenzymeQ10 Markets, finds the market earned revenues of over $80.6 million in 2007 and estimates to reach $199.8 million in 2014.
If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants with an overview of the U.S. CoQ10 markets, send an email to Johanna Haynes, Corporate Communications, at jhaynes_pr[.]frost.com with the following information: your full name, company name, title, company telephone number, company email address, city, state, and country. We will send you the information via email upon receipt of the above information.
The main tasks facing CoQ10 ingredient manufacturers are to establish scientific credibility and effectively communicate the product's benefits to consumers. By doing so, manufacturers will help drive the market in currently dominant applications such as supplements and help generate demand in the functional food and beverage category.
Manufacturers must continue research to reveal new benefits of the product if they are to maintain or grow market share, as scientific corroboration of the benefits of CoQ10 is essential to convince consumers to opt for this product.
Other ingredient markets in prebiotics and phytonutrients have seen leading manufacturers successfully leverage scientific credibility to develop a strong brand. New entrants must be prepared to invest substantially in scientific trials and clinical research to establish credibility, which will play an invaluable role in developing a distinct brand identity.
Meanwhile, as the population of the U.S. ages, consumer concern about mobility and quality of life will increase. The body's ability to synthesize CoQ10 in human tissues decreases with age, and this could have serious consequences. CoQ10 supplements, therefore, will find greater uptake among the elderly.
Burgeoning product development in the market also opens up newer venues of growth for CoQ10 manufacturers. For example, new product development activities reveal new application areas for CoQ10, which is likely to drive market growth. Potential application areas include the food and beverages market.
Since manufacturers of functional foods and beverages choose from a wide range of nutrients when deciding to add to their products, the taste and sensory acceptability of CoQ10 products is very important.
Research has shown that consumers are unwilling to compromise on taste, texture, and other organoleptic properties when it comes to functional food. Technical service and formulation assistance are increasingly necessary tools in developing markets.
U.S. CoenzymeQ10 Markets is part of the Food & Beverage Ingredients Growth Partnership Service program, which also includes research in the following markets: Europe CoenzymeQ10 market, U.S. prebiotics markets, global lutein market, and U.S. essential oils and oleoresins market. All research services included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants. Interviews with the press are available.
Frost & Sullivan, the Global Growth Consulting Company, partners with clients to accelerate their growth. The company's Growth Partnership Services, Growth Consulting and Career Best Practices empower clients to create a growth focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents.
U.S. CoenzymeQ10 Markets N106